Oxybutynin Chloride Tablet
Product Images NDC 43063-851

7 FDA label images from Pd-rx Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 43063-851). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

43063851 Label (43063851)

43063851 Label (43063851)
Label for Oxybutynin Chloride 5 mg tablets USP, oral tablets, 90 count. Marketed and packaged by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, and manufactured by KVK-Tech, Inc., Newtown, PA. The label includes the NDC 43063-851-90, storage instructions, a barcode, and medication usage warnings.*
FDA Label Image

Structural Formula (Figure 1 Structure)

Structural Formula (Figure 1 Structure)
Chemical structure diagram of Oxybutynin Chloride, showing the molecular framework including aromatic rings, alkyl chains, ester, and amine functional groups, as well as the hydrochloride component.*
FDA Label Image

Table 1 (Figure 2 Table1)

Table 1 (Figure 2 Table1)
A data table comparing pharmacokinetic parameters of R-Oxybutynin and S-Oxybutynin, including Cmax, Tmax, AUCt, and AUCinf, with units and mean values alongside standard deviations.*
FDA Label Image

Figure 1 (Figure 3 Figure1)

Figure 1 (Figure 3 Figure1)
A line graph showing mean plasma oxybutynin concentration (ng/mL) over a 24-hour period after dosing with 5 mg oxybutynin taken three times daily (TID). The x-axis represents time in hours, and the y-axis shows plasma concentration levels. Data points include error bars indicating variability.*
FDA Label Image

Table 2 (Figure 4 Table2)

Table 2 (Figure 4 Table2)
A data table showing pharmacokinetic parameters for four chemical forms: R-Oxybutynin, S-Oxybutynin, R-Desethyloxybutynin, and S-Desethyloxybutynin, including Cmax (ng/mL), Tmax (hr), and AUC (ng·hr/mL) values with standard deviations.*
FDA Label Image

Figure 2 (Figure 5 Figure2)

Figure 2 (Figure 5 Figure2)
A line graph showing mean R-Oxybutynin plasma concentration (ng/mL) over time (hours). Concentration peaks at around 1 hour and then declines steadily until 12 hours, with error bars indicating variability at each time point.*
FDA Label Image

Table 3 (Figure 6 Table3)

Table 3 (Figure 6 Table3)
A data table presenting adverse events associated with Oxybutynin Chloride (5-20 mg/day) in 199 patients. The table categorizes side effects by body system, including infections, psychiatric disorders, nervous system disorders, eye disorders, gastrointestinal disorders, and renal/urinary disorders, with corresponding percentages for each adverse event.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.